$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000163297022000045 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$319.0M	$37.84M
YoY Change	742.93%	0.79%
Cost Of Revenue	$287.2M	$245.1M
YoY Change	17.14%	1783.24%
Gross Profit	$31.81M	-$207.3M
YoY Change	-115.35%	-945.2%
Gross Profit Margin	9.97%	-547.82%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$42.31M	$25.72M
YoY Change	64.49%	105.29%
% of Gross Profit	132.99%
Operating Expenses
YoY Change
Operating Profit	$73.68M	$38.08M
YoY Change	93.49%
Interest Expense	$23.33M	$20.37M
YoY Change	14.53%	283.52%
% of Operating Profit	31.66%	53.48%
Other Income/Expense, Net	-$20.81M	-$19.96M
YoY Change	4.24%
Pretax Income	-$729.0K	-$16.11M
YoY Change	-95.47%	103.08%
Income Tax	$168.0K	$163.0K
% Of Pretax Income
Net Earnings	-$2.956M	-$11.85M
YoY Change	-75.05%	52.55%
Net Earnings / Revenue	-0.93%	-31.31%
Basic Earnings Per Share	-$0.01	-$0.07
Diluted Earnings Per Share	-$0.01	-$0.07
COMMON SHARES
Basic Shares Outstanding	262.5M shares	179.6M shares
Diluted Shares Outstanding	262.5M shares	179.6M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$75.12M	$90.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$18.09M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$211.7M
YoY Change
Intangibles	$241.1M	$59.91M
YoY Change	302.53%	-23.43%
Long-Term Investments	$22.73M	$45.75M
YoY Change	-50.32%	-3.22%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$4.556B	$1.087B
YoY Change	319.29%	-3.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$2.750B	$542.9M
YoY Change	406.54%	-0.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$980.6M	-$196.8M
YoY Change	398.19%	30.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.557B	$540.5M
YoY Change
Total Liabilities & Shareholders Equity	$4.556B	$1.087B
YoY Change	319.29%	-3.73%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$2.956M	-$11.85M
YoY Change	-75.05%	52.55%
Depreciation, Depletion And Amortization	$42.31M	$25.72M
YoY Change	64.49%	105.29%
Cash From Operating Activities	$22.36M	-$5.255M
YoY Change	-525.5%	-153.66%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions	$0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$27.37M	-$106.8M
YoY Change	-74.39%	56.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$4.134M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.307M	$89.61M
YoY Change	-101.46%	41.06%
NET CHANGE
Cash From Operating Activities	$22.36M	-$5.255M
Cash From Investing Activities	-$27.37M	-$106.8M
Cash From Financing Activities	-$1.307M	$89.61M
Net Change In Cash	-$6.314M	-$22.49M
YoY Change	-71.93%	-548.21%
FREE CASH FLOW
Cash From Operating Activities	$22.36M	-$5.255M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-55775
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICAN HEALTHCARE REIT, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2887436
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	18191 Von Karman Avenue
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92612
CY2022Q1	dei	City Area Code CityAreaCode	949
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	270-9200
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	12715000	USD
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3475635000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3514686000	USD
CY2022Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	80239000	USD
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	79315000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75115000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81597000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	44055000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	43889000	USD
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	130872000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	122778000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	241140000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	248871000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	211724000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	209898000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154619000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158157000	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	142786000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	121148000	USD
CY2022Q1	us-gaap	Assets Assets	4556185000	USD
CY2021Q4	us-gaap	Assets Assets	4580339000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	1103006000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1095594000	USD
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	1238147000	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	1226634000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	170757000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	187254000	USD
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	USD
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	866000	USD
CY2022Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	12077000	USD
CY2022Q1	gahr	Financing Obligations FinancingObligations	32921000	USD
CY2021Q4	gahr	Financing Obligations FinancingObligations	33653000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	142615000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	145485000	USD
CY2022Q1	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	50574000	USD
CY2021Q4	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	48567000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2750097000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2750768000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	75267000	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	72725000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2536811000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2531940000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-980613000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951303000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2160000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1966000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1556667000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1581293000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	174154000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	175553000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1730821000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1756846000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4556185000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4580339000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	318974000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	253026000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	51943000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	30023000	USD
CY2022Q1	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	5214000	USD
CY2021Q1	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	8229000	USD
CY2022Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	376131000	USD
CY2021Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	291278000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	287160000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	245142000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	15287000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	8055000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11119000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7257000	USD
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	173000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1248000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42311000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25723000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	356050000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	287425000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	23325000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	20365000	USD
CY2022Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	500000	USD
CY2021Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	1821000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	756000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-335000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1386000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1771000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1387000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	415000	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1260000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	272000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20810000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19963000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-729000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16110000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	168000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-897000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-16273000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2059000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4426000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2956000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11847000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	262516815	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	262516815	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	179627778	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	179627778	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-897000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-16273000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-194000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	69000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-194000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	69000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1091000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-16204000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2059000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25723000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4426000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3150000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11778000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1756846000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	11304000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	811000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21000	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4134000	USD
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3515000	USD
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2022Q1	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	-21000	USD
CY2022Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	2856000	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26354000	USD
CY2022Q1	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-1084000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-194000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1730821000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1034483000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	27000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-14000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	176000	USD
CY2021Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	526000	USD
CY2021Q1	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-15789000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	69000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1018073000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	187000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-484000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-897000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-16273000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42311000	USD
CY2022Q1	gahr	Other Amortization OtherAmortization	6166000	USD
CY2021Q1	gahr	Other Amortization OtherAmortization	5955000	USD
CY2022Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1695000	USD
CY2021Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1023000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-32000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-14000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	811000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1386000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1771000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	756000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-335000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1335000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	416000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4591000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2288000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	500000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	1821000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	8300000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-3203000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1432000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4440000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7878000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10891000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-184000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-5160000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4602000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4358000	USD
CY2022Q1	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	5192000	USD
CY2021Q1	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	161000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22360000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5255000	USD
CY2022Q1	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	20856000	USD
CY2021Q1	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	29196000	USD
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	19878000	USD
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	78542000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	14074000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	1248000	USD
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	200000	USD
CY2021Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	325000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	507000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	26000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27367000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106841000	USD
CY2022Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	22489000	USD
CY2021Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	104092000	USD
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4538000	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3480000	USD
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	941400000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	16600000	USD
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	928900000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	18000000	USD
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4796000	USD
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	799000	USD
CY2022Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2790000	USD
CY2021Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	125000	USD
CY2022Q1	gahr	Payments On Financing Obligations PaymentsOnFinancingObligations	787000	USD
CY2021Q1	gahr	Payments On Financing Obligations PaymentsOnFinancingObligations	8481000	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15010000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4134000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	3511000	USD
CY2021Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	172000	USD
CY2022Q1	gahr	Proceedsfromredeemablenoncontrollinginterest Proceedsfromredeemablenoncontrollinginterest	173000	USD
CY2021Q1	gahr	Proceedsfromredeemablenoncontrollinginterest Proceedsfromredeemablenoncontrollinginterest	0	USD
CY2022Q1	gahr	Paymentsto Redeemable Noncontrolling Interest PaymentstoRedeemableNoncontrollingInterest	695000	USD
CY2021Q1	gahr	Paymentsto Redeemable Noncontrolling Interest PaymentstoRedeemableNoncontrollingInterest	0	USD
CY2022Q1	gahr	Increasedecreaseinsecuritydepositsandother Increasedecreaseinsecuritydepositsandother	-208000	USD
CY2021Q1	gahr	Increasedecreaseinsecuritydepositsandother Increasedecreaseinsecuritydepositsandother	-30000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1307000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	89605000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6314000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-22491000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125486000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152190000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119170000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129706000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81597000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113212000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	43889000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	38978000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125486000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152190000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75115000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89995000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	44055000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	39711000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119170000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129706000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	18916000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	16079000	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	191000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	169000	USD
CY2022Q1	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	14750000	USD
CY2021Q1	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	16020000	USD
CY2022Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	223000	USD
CY2021Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	41000	USD
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	11304000	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8794000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2022Q1	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	467000	USD
CY2021Q1	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	0	USD
CY2022Q1	gahr	Finance Leasesequipmentandautoobligationsincurred FinanceLeasesequipmentandautoobligationsincurred	0	USD
CY2021Q1	gahr	Finance Leasesequipmentandautoobligationsincurred FinanceLeasesequipmentandautoobligationsincurred	136000	USD
CY2022Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	-173000	USD
CY2021Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	4000	USD
CY2022Q1	gahr	Noncashor Part Noncash Acquisitionsand Disposals Increase Decreasein Other Assets NoncashorPartNoncashAcquisitionsandDisposalsIncreaseDecreaseinOtherAssets	5023000	USD
CY2021Q1	gahr	Noncashor Part Noncash Acquisitionsand Disposals Increase Decreasein Other Assets NoncashorPartNoncashAcquisitionsandDisposalsIncreaseDecreaseinOtherAssets	-190000	USD
CY2022Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Mortgage Loans Payable Assumed NoncashOrPartNoncashAcquisitionAndDisposalsMortgageLoansPayableAssumed	-12059000	USD
CY2021Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Mortgage Loans Payable Assumed NoncashOrPartNoncashAcquisitionAndDisposalsMortgageLoansPayableAssumed	0	USD
CY2022Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	-21000	USD
CY2021Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	0	USD
CY2022Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	56000	USD
CY2021Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	0	USD
CY2022Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	7746000	USD
CY2021Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	0	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview and Background</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc., a Maryland corporation, owns a diversified portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing, hospitals and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). Our healthcare facilities operated under a RIDEA structure include our senior housing operating properties, or SHOP (formerly known as senior housing — RIDEA), and our integrated senior health campuses. We have originated and acquired secured loans and may also originate and acquire other real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income; however, we have selectively developed, and may continue to selectively develop, healthcare real estate properties. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes, and we intend to continue to qualify to be taxed as a REIT. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger of Griffin-American Healthcare REIT III, Inc. and Griffin-American Healthcare REIT IV, Inc.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2021, pursuant to an Agreement and Plan of Merger dated June 23, 2021, or the Merger Agreement, GAHR III merged with and into Continental Merger Sub, LLC, a Maryland limited liability company and newly formed wholly owned subsidiary of GAHR IV, or Merger Sub, with Merger Sub being the surviving company, or the REIT Merger. On October 1, 2021, also pursuant to the Merger Agreement, Griffin-American Healthcare REIT IV Holdings, LP, a Delaware limited partnership and subsidiary and operating partnership of GAHR IV, or GAHR IV Operating Partnership, merged with and into Griffin-American Healthcare REIT III Holdings, LP, a Delaware limited partnership, or our operating partnership, with our operating partnership being the surviving entity, or the Partnership Merger. We collectively refer to the REIT Merger and the Partnership Merger as the Merger. Following the Merger on October 1, 2021, our company, or the Combined Company, was renamed American Healthcare REIT, Inc. and our operating partnership, also referred to as the surviving partnership, was renamed American Healthcare REIT Holdings, LP. The REIT Merger qualified as a reorganization under, and within the meaning of, Section 368(a) of the Code. As a result of and at the effective time of the Merger, the separate corporate existence of GAHR III and GAHR IV Operating Partnership ceased.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the effective time of the REIT Merger, each issued and outstanding share of GAHR III’s common stock, $0.01 par value per share, converted into the right to receive 0.9266 shares of GAHR IV’s Class I common stock, $0.01 par value per share. At the effective time of the Partnership Merger, (i) each unit of limited partnership interest in our operating partnership outstanding as of immediately prior to the effective time of the Partnership Merger was converted automatically into the right to receive 0.9266 of a Partnership Class I Unit, as defined in the agreement of limited partnership, as amended, of the surviving partnership and (ii) each unit of limited partnership interest in GAHR IV Operating Partnership outstanding as of immediately prior to the effective time of the Partnership Merger was converted automatically into the right to receive one unit of limited partnership interest of the surviving partnership of like class.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">AHI Acquisition</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on October 1, 2021, immediately prior to the consummation of the Merger, GAHR III acquired a newly formed entity, American Healthcare Opps Holdings, LLC, or NewCo, which we refer to as the AHI Acquisition, pursuant to a contribution and exchange agreement dated June 23, 2021, or the Contribution Agreement, between GAHR III; our operating partnership; American Healthcare Investors, LLC, or AHI; Griffin Capital Company, LLC, or Griffin Capital; Platform Healthcare Investor T-II, LLC; Flaherty Trust; and Jeffrey T. Hanson, our former Chief Executive Officer and current Executive Chairman of the Board of Directors, Danny Prosky, our former Chief Operating Officer and current Chief Executive Officer and President, and Mathieu B. Streiff, our former Executive Vice President, General Counsel and current Chief </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Officer, or collectively, the AHI Principals. NewCo owned substantially all of the business and operations of AHI, as well as all of the equity interests in (i) Griffin-American Healthcare REIT IV Advisor, LLC, or GAHR IV Advisor, a subsidiary of AHI that served as the external advisor of GAHR IV, and (ii) Griffin-American Healthcare REIT III Advisor, LLC, or GAHR III Advisor, also referred to as our former advisor, a subsidiary of AHI that served as the external advisor of GAHR III. See “Operating Partnership and Former Advisor” below for a further discussion. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Contribution Agreement, AHI contributed substantially all of its business and operations to the surviving partnership, including its interest in GAHR III Advisor and GAHR IV Advisor, and Griffin Capital contributed its then-current ownership interest in GAHR III Advisor and GAHR IV Advisor to the surviving partnership. In exchange for these contributions, the surviving partnership issued limited partnership units, or surviving partnership OP units. Subject to working capital and other customary adjustments, the total approximate value of these surviving partnership OP units at the time of consummation of the transactions contemplated by the Contribution Agreement was approximately $131,674,000, with a reference value for purposes thereof of $8.71 per unit, such that the surviving partnership issued 15,117,529 surviving partnership OP units as consideration, or the Closing Date Consideration. Following the consummation of the Merger and the AHI Acquisition, the Combined Company became self-managed. As of March 31, 2022 and December 31, 2021, such surviving partnership OP units are owned by AHI Group Holdings, LLC, or AHI Group Holdings, which is owned and controlled by the AHI Principals, Platform Healthcare Investor T-II, LLC, Flaherty Trust and a wholly owned subsidiary of Griffin Capital, or collectively, the NewCo Sellers. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AHI Acquisition was treated as a business combination for accounting purposes, with GAHR III as both the legal and accounting acquiror of NewCo. While GAHR IV was the legal acquiror of GAHR III in the REIT Merger, GAHR III was determined to be the accounting acquiror in the REIT Merger in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, after considering the relative share ownership and the composition of the governing body of the Combined Company. Thus, the financial information set forth herein subsequent to the consummation of the Merger and the AHI Acquisition reflects results of the Combined Company, and the financial information set forth herein prior to the Merger and the AHI Acquisition reflects GAHR III’s results. For this reason, period to period comparisons may not be meaningful. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Partnership and Former Advisor</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct substantially all of our operations through our operating partnership. Through September 30, 2021, we were externally advised by our former advisor pursuant to an advisory agreement, as amended, or the Advisory Agreement, between us and our former advisor. Our former advisor used its best efforts, subject to the oversight and review of our board of directors, or our board, to, among other things, provide asset management, property management, acquisition, disposition and other advisory services on our behalf consistent with our investment policies and objectives.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Merger and the AHI Acquisition, we became self-managed and are no longer externally advised. As a result, any fees that would have otherwise been payable to our former advisor are no longer being paid. Also, on October 1, 2021 and in connection with the AHI Acquisition, our operating partnership redeemed all 22,222 shares of our common stock owned by our former advisor and the 20,833 shares of our Class T common stock owned by GAHR IV Advisor in GAHR IV. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger and the AHI Acquisition, our former advisor was 75.0% owned and managed by wholly owned subsidiaries of AHI, and 25.0% owned by a wholly owned subsidiary of Griffin Capital, or collectively, our former co-sponsors. Prior to the AHI Acquisition, AHI was 47.1% owned by AHI Group Holdings, 45.1% indirectly owned by Digital Bridge Group, Inc. (NYSE: DBRG), or Digital Bridge, and 7.8% owned by James F. Flaherty III. We were not affiliated with Griffin Capital, Digital Bridge or Mr. Flaherty; however, we were affiliated with our former advisor, AHI and AHI Group Holdings. Please see the “Merger of Griffin-American Healthcare REIT III, Inc. and Griffin-American Healthcare REIT IV, Inc.” and “AHI Acquisition” sections above for a further discussion of our operations effective October 1, 2021. See Note 13, Redeemable Noncontrolling Interests, and Note 14, Equity — Noncontrolling Interests in Total Equity, for a further discussion of the ownership in our operating partnership.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offering</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, we raised $1,842,618,000 through a best efforts initial public offering that commenced on February 26, 2014, or the GAHR III initial offering, and issued 184,930,598 shares of our common stock. In addition, during the GAHR III initial offering, we issued 1,948,563 shares of our common stock pursuant to our initial distribution reinvestment plan, or the Initial DRIP, for a total of $18,511,000 in distributions reinvested. Following the deregistration of the GAHR III initial offering on April 22, 2015, we continued issuing shares of our common stock pursuant to subsequent distribution reinvestment plan offerings.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14, Equity — Common Stock, and Note 14, Equity — Distribution Reinvestment Plan, for a further discussion of our public offerings.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Real Estate Investments Portfolio</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate through six reportable business segments: medical office buildings, integrated senior health campuses, skilled nursing facilities, SHOP, senior housing and hospitals. As of March 31, 2022, we owned and/or operated 182 properties, comprising 191 buildings, and 122 integrated senior health campuses including completed development projects, or approximately 19,461,000 square feet of gross leasable area, or GLA, for an aggregate contract purchase price of $4,299,872,000, including the fair value of the properties acquired in the Merger. In addition, as of March 31, 2022, we also owned a real estate-related debt investment purchased for $60,429,000.</span></div><div style="margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our residents, tenants, operating partners and managers, our industry and the U.S. economy continue to be disrupted by the COVID-19 pandemic and related supply chain disruptions and labor shortages. The timing and extent of the economic recovery from the COVID-19 pandemic is dependent upon many factors, including the rate of vaccination, the emergence and severity of COVID-19 variants, the continued effectiveness of the vaccines against those variants, the frequency of booster vaccinations and the duration and implications of continued restrictions and safety measures. As the COVID-19 pandemic is still impacting the healthcare system to a certain extent, it continues to present challenges for us as an owner and operator of healthcare facilities, making it difficult to ascertain the long-term impact the COVID-19 pandemic will have on real estate markets in which we own and/or operate properties and our portfolio of investments. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the impacts of the COVID-19 pandemic on our business thus far and incorporated information concerning such impacts into our assessments of liquidity, impairment and collectability from tenants and residents as of March 31, 2022. We will continue to monitor such impacts and will adjust our estimates and assumptions based on the best available information.</span></div>
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
	gahr	Numberof Properties Acquiredfrom Unaffiliated Parties NumberofPropertiesAcquiredfromUnaffiliatedParties	182	Property
	gahr	Number Of Buildings Acquired From Unaffiliated Parties NumberOfBuildingsAcquiredFromUnaffiliatedParties	191	Building
	gahr	Number Of Integrated Senior Health Campuses Acquired From Unaffiliated Parties NumberOfIntegratedSeniorHealthCampusesAcquiredFromUnaffiliatedParties	122	Campus
CY2022Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	19461000	sqft
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price Netof Disposals AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePriceNetofDisposals	4299872000	USD
	gahr	Acquisitionaggregatedcostofacquiredrealestaterelatedinvestmentspurchasepricenetofprincipalrepayments Acquisitionaggregatedcostofacquiredrealestaterelatedinvestmentspurchasepricenetofprincipalrepayments	60429000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions, including through business combinations, goodwill and its impairment, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
CY2021Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	36440000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tenant and Resident Receivables and Allowances</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations and comprehensive loss. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for uncollectible amounts, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations and comprehensive loss.</span></div>
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13872000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12378000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	5223000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	2478000	USD
CY2022Q1	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	-2099000	USD
CY2021Q1	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	-1505000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1630000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1606000	USD
CY2022Q1	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	28456000	USD
CY2021Q4	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	31101000	USD
CY2022Q1	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	35294000	USD
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	22102000	USD
CY2022Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	21654000	USD
CY2022Q1	gahr	Accrued Developments And Capital Expenditures AccruedDevelopmentsAndCapitalExpenditures	14750000	USD
CY2021Q4	gahr	Accrued Developments And Capital Expenditures AccruedDevelopmentsAndCapitalExpenditures	22852000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8794000	USD
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8768000	USD
CY2021Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	101734000	USD
CY2022Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4031430000	USD
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4038572000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	555795000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	523886000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3475635000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3514686000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	34422000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	24190000	USD
CY2022Q1	gahr	Sale Of Ownership Interest In Real Estate Percent SaleOfOwnershipInterestInRealEstatePercent	0.770
CY2022Q1	gahr	Contract Sale Price Of Disposition ContractSalePriceOfDisposition	19622000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	756000	USD
CY2022Q1	gahr	Ownership Interest In Real Estate Percent OwnershipInterestInRealEstatePercent	0.230
CY2022Q1	gahr	Ownership Interest In Real Estate Percent OwnershipInterestInRealEstatePercent	0.230
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	1558000	USD
CY2022Q1	gahr	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Certificates Of Need BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCertificatesOfNeed	690000	USD
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	588000	USD
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	56000	USD
CY2022Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	80239000	USD
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	79315000	USD
CY2022Q1	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	948000	USD
CY2021	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	1004000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	980000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	881000	USD
CY2022Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	56000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	47000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	241140000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	248871000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8239000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1196000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P8Y8M12D
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P8Y9M18D
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	16985000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17202000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13673000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11034000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9864000	USD
CY2022Q1	gahr	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	45015000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	113773000	USD
CY2022Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	42672000	USD
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	41061000	USD
CY2022Q1	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	33818000	USD
CY2021Q4	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	22484000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	22726000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	15615000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	18087000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	18929000	USD
CY2022Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	5100000	USD
CY2021Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	4911000	USD
CY2022Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	16283000	USD
CY2021Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	16120000	USD
CY2022Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	3668000	USD
CY2021Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8469000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6130000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3781000	USD
CY2022Q1	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	1930000	USD
CY2021Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	1842000	USD
CY2022Q1	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P8Y8M12D
CY2021	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P8Y10M24D
CY2022Q1	us-gaap	Incentive To Lessee IncentiveToLessee	3070000	USD
CY2021Q4	us-gaap	Incentive To Lessee IncentiveToLessee	3158000	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	142786000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	121148000	USD
CY2022Q1	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	USD
CY2021Q1	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1121901000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	1103006000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1116216000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1095594000	USD
CY2022Q1	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	67	MortgageLoan
CY2022Q1	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	11	MortgageLoan
CY2021Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	66	MortgageLoan
CY2021Q4	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	12	MortgageLoan
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1121901000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1116216000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	356000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	397000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10937000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12339000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	1103006000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1095594000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1095594000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	810478000	USD
CY2022Q1	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	88659000	USD
CY2021Q1	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	205826000	USD
CY2022Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	2078000	USD
CY2021Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	2627000	USD
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	4538000	USD
CY2021Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	3480000	USD
CY2022Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	78437000	USD
CY2021Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	101734000	USD
CY2022Q1	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	333000	USD
CY2021Q1	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	1037000	USD
CY2022Q1	gahr	Long Term Debt Without Lender Approval LongTermDebtWithoutLenderApproval	14137000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-17000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	203000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	1103006000	USD
CY2021Q1	us-gaap	Secured Debt SecuredDebt	912883000	USD
CY2022Q1	gahr	Numberofdebtinstrumentsextinguished Numberofdebtinstrumentsextinguished	8	MortgageLoan
CY2021Q1	gahr	Numberofdebtinstrumentsextinguished Numberofdebtinstrumentsextinguished	10	MortgageLoan
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	121952000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	121130000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	163974000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	29571000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	155402000	USD
CY2022Q1	gahr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	529872000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1121901000	USD
CY2022Q1	gahr	Mortgage Loans Without Lender Approval MortgageLoansWithoutLenderApproval	2	MortgageLoan
CY2022Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	500000	USD
CY2021Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	1821000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	1239000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	1596000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	1475000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	1347000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	1198000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	5222000	USD
CY2022Q1	gahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	12077000	USD
CY2022Q1	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	72725000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	40340000	USD
CY2022Q1	gahr	Additional Redeemable Noncontrolling Interests AdditionalRedeemableNoncontrollingInterests	173000	USD
CY2021Q1	gahr	Additional Redeemable Noncontrolling Interests AdditionalRedeemableNoncontrollingInterests	0	USD
CY2022Q1	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	-21000	USD
CY2021Q1	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	0	USD
CY2022Q1	gahr	Paymentsto Redeemable Noncontrolling Interest PaymentstoRedeemableNoncontrollingInterest	695000	USD
CY2021Q1	gahr	Paymentsto Redeemable Noncontrolling Interest PaymentstoRedeemableNoncontrollingInterest	0	USD
CY2022Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	2856000	USD
CY2021Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	526000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	187000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-484000	USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	75267000	USD
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	40382000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	gahr	Maximum Amount Of Common Stock Issuable Under Public Offering Reserved Shares MaximumAmountOfCommonStockIssuableUnderPublicOfferingReservedShares	33110893	shares
CY2014Q1	gahr	Maximum Percentage Of Common Stock Repurchased During Period MaximumPercentageOfCommonStockRepurchasedDuringPeriod	0.050
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4134000	USD
CY2022Q1	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.22
CY2016Q1	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	125000	USD
CY2022Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.125	Rate
CY2022Q1	gahr	Proceeds From Issuanceof Noncontrolling Interest ProceedsFromIssuanceofNoncontrollingInterest	11000000	USD
CY2021	gahr	Proceeds From Issuanceof Noncontrolling Interest ProceedsFromIssuanceofNoncontrollingInterest	11000000	USD
CY2022Q1	gahr	Operating Partnership Units Outstanding Presented In Total Equity Percent OperatingPartnershipUnitsOutstandingPresentedInTotalEquityPercent	0.040
CY2021Q4	gahr	Operating Partnership Units Outstanding Presented In Total Equity Percent OperatingPartnershipUnitsOutstandingPresentedInTotalEquityPercent	0.041
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1082455	shares
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	811000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	27000	USD
CY2021Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	7973000	USD
CY2022Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	866000	USD
CY2022Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	80239000	USD
CY2022Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93859000	USD
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	79315000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93920000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	1103006000	USD
CY2022Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1039112000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1095594000	USD
CY2021Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1075729000	USD
CY2022Q1	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	1232017000	USD
CY2022Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1243616000	USD
CY2021Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	1222853000	USD
CY2021Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1226636000	USD
CY2022Q1	gahr	Operating Lease Revenue OperatingLeaseRevenue	50731000	USD
CY2021Q1	gahr	Operating Lease Revenue OperatingLeaseRevenue	28667000	USD
CY2022Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	10413000	USD
CY2021Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	4350000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	111923000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	143369000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	132178000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	119475000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	109477000	USD
CY2022Q1	gahr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	612203000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1228625000	USD
CY2022Q1	gahr	Lessee Operating Lease Lease Not Yet Commenced LesseeOperatingLeaseLeaseNotYetCommenced	27229000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6356000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6337000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	312000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	412000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	74000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	118000	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	147000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	6595000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	6867000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y10M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y10M24D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0552
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0757
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0768
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	74000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	118000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	60000	USD
CY2022Q1	gahr	Leasedassetsobtainedinexchangeforfinanceleaseliabilities Leasedassetsobtainedinexchangeforfinanceleaseliabilities	56000	USD
CY2021Q1	gahr	Leasedassetsobtainedinexchangeforfinanceleaseliabilities Leasedassetsobtainedinexchangeforfinanceleaseliabilities	138000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	14522000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	19275000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	18245000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	17190000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	16851000	USD
CY2022Q1	gahr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	163815000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	249898000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	107283000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	142615000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	51000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	61000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	75000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	31000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2022Q1	gahr	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	218000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	27000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	191000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2021Q4	gahr	Number Of Properties Acquired NumberOfPropertiesAcquired	87	Property
CY2021Q4	gahr	Number Of Buildings Acquired NumberOfBuildingsAcquired	92	Building
CY2021Q4	gahr	Number Of Square Feet Of Property Acquired NumberOfSquareFeetOfPropertyAcquired	4799000	sqft
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	318974000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	51943000	USD
CY2022Q1	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	5214000	USD
CY2022Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	376131000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	287160000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	15287000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	73684000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11119000	USD
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	173000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42311000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	23325000	USD
CY2022Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	500000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	756000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1386000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1387000	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1260000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20810000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-729000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	168000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-897000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	253026000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	30023000	USD
CY2021Q1	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	8229000	USD
CY2021Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	291278000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	245142000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	8055000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	38081000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7257000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1248000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25723000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	20365000	USD
CY2021Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	1821000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-335000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1771000	USD
CY2021Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	291278000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	272000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19963000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	415000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16110000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-16273000	USD
CY2022Q1	us-gaap	Assets Assets	4556185000	USD
CY2021Q4	us-gaap	Assets Assets	4580339000	USD
CY2022Q1	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	376131000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3475635000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3514686000	USD
CY2022Q1	gahr	Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent	1	State
CY2022Q1	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.100
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2022Q1	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	0	tenant
CY2022Q1	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1490000	USD
CY2021Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	0	USD

Files In Submission

Name	View Source	Status
0001632970-22-000045-index-headers.html	Edgar Link	pending
0001632970-22-000045-index.html	Edgar Link	pending
0001632970-22-000045.txt	Edgar Link	pending
0001632970-22-000045-xbrl.zip	Edgar Link	pending
ex311-2022xq110xqahr.htm	Edgar Link	pending
ex312-2022xq110xqahr.htm	Edgar Link	pending
ex321-2022xq110xqahr.htm	Edgar Link	pending
ex322-2022xq110xqahr.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gahr-20220331.htm	Edgar Link	pending
gahr-20220331.xsd	Edgar Link	pending
gahr-20220331_cal.xml	Edgar Link	unprocessable
gahr-20220331_def.xml	Edgar Link	unprocessable
gahr-20220331_htm.xml	Edgar Link	completed
gahr-20220331_lab.xml	Edgar Link	unprocessable
gahr-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2022 Q1 Form 10-Q Financial Statement

#000163297022000045 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2022 Q1 Form 10-Q Financial Statement

#000163297022000045 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr